Previously we demonstrated that schistosome egg glycans are largely responsible for parasite induced immunomodulation and Th2-biasing. We identified LNFPIII and LNnT as two glycans present on schistosome eggs that drive immune modulation in vifro and in vivo. These glycans induce immune suppression and CD4+ Th2-type responses when presented 10 antigen presenting cells as glyco-conjugales. The overall goal of this renewal application is to understand how defined schistosome glycans activate APCs in such a manner that these APCs drive anti-inflammatory responses. Alternative activation of human DCs by soluble egg antigens occurs through three Ctype lectins: mannose receptor (MR), macrophage galactose receptor (MgI) and DC-SIGN. LNFPIlI binds to each of these lectins and to MSIGNR1 . Therefore we will perform experiments in mice deficient in these lectins or use HEK cells singly transfected with these lectins to examine their roles in LNFPIII induced APC activation. In addition, by transfecting HEK cells expressing TLR4/CD14/MD2 with these same C-type lectins we will determine if activation of APes via these lectins alters Toll-like receptor induced signaling. Because C-type lectin-ligand interaction leads to endosome formation, we will examine the role endosome formation plays in alternative activation using inhibitors of endosome formation. We have performed microarray analysis to examine signaling pathways downstream of LNFPlIl activation and Identify candidate genes. We will use RT -PCR to validate several candidate genes and then siRNA to knockdown these genes to determine if their role is critical for alternative activation. For proteins we will use Rules Based Medicine (RBM) analysis to measure levels of >72 proteins known to be involved in innate activation of APCs.
The specific aims are: 1) What roles do specific C-type lectins and endosome formation play in driving LNFPIII induction of alternative activation of APCs? 2) Determine if candidate signaling molecules and soluble factors are required for LNFPIII induced altemative activation of APCs?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI056484-05A2
Application #
7525378
Study Section
Pathogenic Eukaryotes Study Section (PTHE)
Program Officer
Wali, Tonu M
Project Start
2003-07-22
Project End
2011-06-30
Budget Start
2009-07-22
Budget End
2010-06-30
Support Year
5
Fiscal Year
2009
Total Cost
$374,029
Indirect Cost
Name
University of Georgia
Department
Microbiology/Immun/Virology
Type
Schools of Veterinary Medicine
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Tundup, Smanla; Srivastava, Leena; Norberg, Thomas et al. (2015) A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway. PLoS One 10:e0137495
Marrache, Sean; Tundup, Smanla; Harn, Donald A et al. (2015) Ex vivo generation of functional immune cells by mitochondria-targeted photosensitization of cancer cells. Methods Mol Biol 1265:113-22
Tundup, Smanla; Srivastava, Leena; Nagy, Tamas et al. (2014) CD14 influences host immune responses and alternative activation of macrophages during Schistosoma mansoni infection. Infect Immun 82:3240-51
Srivastava, Leena; Tundup, Smanla; Choi, Beak-San et al. (2014) Immunomodulatory glycan lacto-N-fucopentaose III requires clathrin-mediated endocytosis to induce alternative activation of antigen-presenting cells. Infect Immun 82:1891-903
Pathak, Rakesh K; Marrache, Sean; Harn, Donald A et al. (2014) Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate. ACS Chem Biol 9:1178-87
Marrache, Sean; Tundup, Smanla; Harn, Donald A et al. (2013) Ex vivo programming of dendritic cells by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy. ACS Nano 7:7392-402
Marrache, Sean; Choi, Joshua H; Tundup, Smanla et al. (2013) Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer. Integr Biol (Camb) 5:215-23
Bhargava, Prerna; Li, Changlin; Stanya, Kristopher J et al. (2012) Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Nat Med 18:1665-72
Tundup, Smanla; Srivastava, Leena; Harn Jr, Donald A (2012) Polarization of host immune responses by helminth-expressed glycans. Ann N Y Acad Sci 1253:E1-E13
Wang, Yang; Da'Dara, Akram A; Thomas, Paul G et al. (2010) Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses. Immunology 129:406-17

Showing the most recent 10 out of 14 publications